SP

Suvidha Pal

Active Director Director DIN 09670699
DIN 09670699 First appointment Jul 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value •••• Premium profile

About Suvidha Pal

Data last updated:

Suvidha Pal is a Director at Vengbo Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Vengbo Pharmaceuticals Private Limited reported revenue of ₹1.6 Lakh (FY 2023).

DIN 09670699
Primary Designation Director
Industry Chemicals
First Appointment 12 Jul 2022
Oldest Company Age 4 yrs
Largest company Vengbo Pharmaceuticals Private Limited · ₹1.6 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Jul 20222022₹1.6 Lakh (FY 2023)Active

Board colleagues of Suvidha Pal

NameDINCompanyDesignation
Sanjay Pal09670698Vengbo Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vengbo Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Suvidha Pal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suvidha Pal

Suvidha Pal currently holds 1 directorship: Vengbo Pharmaceuticals Private Limited (Director, since 12 Jul 2022, revenue ₹1.6 Lakh (FY 2023)).

Suvidha Pal was first appointed on 12 Jul 2022 as Director at Vengbo Pharmaceuticals Private Limited.

The current boards of Suvidha Pal's companies include Sanjay Pal (Vengbo Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available